Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial
AKT 抑制剂 MK-2206 对可手术浸润性乳腺癌患者的术前试验:纽约癌症联盟试验
期刊:Clinical & Translational Oncology
影响因子:2.8
doi:10.1007/s12094-018-1888-2
K Kalinsky, J A Sparano, X Zhong, E Andreopoulou, B Taback, L Wiechmann, S M Feldman, P Ananthakrishnan, A Ahmad, S Cremers, A N Sireci, J R Cross, D K Marks, P Mundi, E Connolly, K D Crew, M A Maurer, H Hibshoosh, S Lee, D L Hershman